Health Care Cost Increases – The Question is How Fast?

doctors scope

Rapid advances in health care treatments may help us live longer and healthier lives. For that to come true, we will have to afford the treatments. Today that is a stretch and affordability may diminish as time passes. The cost burden for health care is already astronomical and there are few promising strategies for cost […]

ACI Capitol Hill Event Highlights Benefits of Biosimilars Competition for Patients and Taxpayers

drug vials

WASHINGTON, Dec. 9, 2014 /PRNewswire-USNewswire/ — The American Consumer Institute Center for Citizen Research (ACI) today hosted an event on Capitol Hill bringing together a panel of experts highlighting the dramatic benefits that unimpeded biosimilars competition would mean for both patients and taxpayers. The event was held as the Food and Drug Administration (FDA) is […]

GMOs — No Room for Imaginary Problems

crops

Agricultural production faces a steep challenge as the world population is expected to grow from 7 billion to 10 billion by 2050.  Many aspects of agriculture and consumer expectations will change in order for another 3 billion people to sit at the table. The agricultural retooling will take place while nations juggle environmental factors such […]

Stratospheric Drug Prices Are Curable

drug vials

Most of American’s activity is focused on work, education, entertainment, and social interactions. Some exercise intentionally to maintain their health and some get healthful exercise through their employment, but it’s unlikely that much of our attention is focused on health care.  One sixth of our economy is tied to health care, but we can remain […]

A Welcomed Primary Care Provider

doctors scope

The scheduling delay for a routine appointment with one of America’s 210,000 primary care doctors seems to be measured in weeks, even when the doctor’s practice is already the patient’s medical home.  New patient appointments often take six weeks.  For a good ophthalmologist, 2 or three months seems to be a normal wait.  Medical care […]

ACI in Forbes: FDA Action Can Save Lives, Money

drug vials

Dr. Joseph Fuhr, Jr., professor of Economics and a senior fellow at ACI, wrote a piece on how biosimilar competition could provide wider choice and cheaper access to lifesaving drugs for patients, but the FDA needs to write the rules necessary to permit competitive entry. His piece is available to read and print at Forbes.

ACI in the Huffington Post: FDA Delays Will Cost Money and Lives

the-huffington

This article, written by ACI president Steve Pociask, discusses the benefits of biosimilar dugs.  These drugs are generic-like versions of lifesaving brand named biopharmaceutical drugs, called biologics.  Europe has had biosimilar competition since 2006, but the U.S. has yet to approve a single biosimilar drug for U.S. patients.  The article calls on the FDA to accelerate its rulemaking and write […]

FDA’s Continued Delay Could Cost Lives

doctors scope

Just last week, Swiss drugmaker Novartis AG applied to create the first generic version of a brand named biologic drug for use in the United States. Their drug, a white blood cell stimulant, would be of great benefit to millions of cancer patients spending every last dime on incredibly expensive biologics.  Generic versions of name […]